Cohen Global, Ltd.

This early-stage study is testing the safety of a new injectable drug called MD-18 in healthy adults who are overweight or have obesity. Over four weeks, 54 participants will receive either the drug or a placebo injection to see how their bodies react. The main goal is to check f…